| Product |
CAS |
Molecular formula |
More |
| (5Z,13e,15s,17z)-15-hydroxy-9-oxo-prosta-5,8(12),13,17-tetraen-1-oicac |
36614-32-1 |
C20H28O4 |
More |
| 1-Palmitoyl-2-thiopalmitoyl phosphatidylcholine |
113881-60-0 |
C40H80NO7PS |
More |
| 3-[1-[(4-Chlorophenyl)methyl]-5-fluoro-3-methylindol-2-yl]-2,2-dimethy |
103253-15-2 |
C21H21ClFNO2 |
More |
| (13E)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid |
20897-91-0 |
C20H34O5 |
More |
| (Z)-7-[2beta-[(1e,3r)-3-hydroxy-4-(3-chlorophenoxy)-1-butenyl]-3alpha, |
56687-85-5 |
C23H31ClO6 |
More |
| (9S,10e,12z,15z)-9-hydroperoxyoctadeca-10,12,15-trienoic acid |
111004-08-1 |
C18H30O4 |
More |
| Piriprost potassium salt |
88851-62-1 |
C26H34KNO4 |
More |
| 4-{4-(4-Fluorophenyl)-2-[4-(methylsulfonyl)phenyl]-1h-imidazol-5-yl}py |
152121-46-5 |
C21H16FN3O2S |
More |
| Methyl (z)-7-[(2r)-3,5-dihydroxy-2-[(e)-3-hydroxy-4-[3-(trifluoromethy |
73275-76-0 |
C24H31F3O6 |
More |
| (9Z,11e,13s,15z)-13-hydroxy-9,11,15-octadecatrienoic acid |
87984-82-5 |
C18H30O3 |
More |
| Jwh-019 6-hydroxyhexyl |
1435934-29-4 |
C25H25NO2 |
More |
| 6-[(1Z,3z,6z,9z)-1,3,6,9-pentadecatetraen-1-yl]tetrahydro-2h-pyran-2-o |
73279-37-5 |
C20H30O2 |
More |
| 15-Oxo-5,8,11-cis-13-trans-eicosatetraenoic acid |
81416-72-0 |
C20H30O3 |
More |
| (9Z,11e,13s)-13-hydroxyoctadeca-9,11-dienoic acid |
10219-69-9 |
C18H32O3 |
More |
| 20-Hydroxy prostaglandin e2 |
57930-95-7 |
C20H32O6 |
More |
| (5Z,11a,13e,15r)-11,15-dihydroxy-16,16-dimethyl-9-methylene-prosta-5,1 |
122576-55-0 |
C23H37KO4 |
More |
| 4-Acetamidophenyl (5z,11alpha,13e,15s)-11,15-dihydroxy-9-oxoprosta-5,1 |
57790-52-0 |
C28H39NO6 |
More |
| 4-(Benzoylamino)phenyl (5z,11alpha,13e,15s)-11,15-dihydroxy-9-oxoprost |
57790-53-1 |
C33H41NO6 |
More |
| (5Z,9alpha,12e,14e)-9-hydroxy-11-oxoprosta-5,12,14-trien-1-oic acid |
85235-11-6 |
C20H30O4 |
More |
| D-myo-inositol 1,4,5-tris(dihydrogen phosphate) hexapotassium salt |
103476-24-0 |
C6H9K6O15P3 |
More |
|
